Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (4 ops.)
Latest filing published 13 Jul 2026 for UNITED THERAPEUTICS Corp. Read the official filing
Filing timeline
BuySaleChristopher Patusky
Insider track record
Disclosed buys
1
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Christopher Patusky: trading record in brief
Christopher Patusky (board member) discloses dealings in UNITED THERAPEUTICS Corp to SEC (Form 4). The record holds 32 filings, for trades running from 7 January 2016 to 9 July 2026.
Market trades split into 1 purchase (€341) and 4 sales (€2.7M). Sales outweigh purchases by €2.7M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 26 option exercises. So far in 2026, the count stands at no purchases and 2 sales.
The latest filing, published on 13 July 2026, reports an option exercise in UNITED THERAPEUTICS Corp. The last insider purchase was made public on 3 May 2023, 1,264 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Christopher Patusky
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations32 total
650 shares0Common StockSEC:0001231427-26-000003:0
2,910 shares@ US$101.800.0012% mcap3.6% of flowCommon StockSEC:0001231427-26-000002:0
2,910 shares@ US$569.000.0068% mcap20.4% of flowCommon StockSEC:0001231427-26-000002:1
1,000 shares@ US$101.800.0004% mcap1.1% of flowCommon StockSEC:0001231427-26-000001:0
1,000 shares@ US$578.880.0024% mcap6.5% of flowCommon StockSEC:0001231427-26-000001:1
1,000 shares@ US$101.801.3% of flowCommon StockSEC:0001231427-25-000004:0
590 shares0Common StockSEC:0001562180-25-005530:0
5,000 shares@ US$175.4315.2% of flowCommon StockSEC:0001562180-25-002636:0
5,000 shares@ US$175.4316.1% of flowCommon StockSEC:0001562180-25-000328:0
700 shares@ US$175.432.1% of flowCommon StockSEC:0001415889-24-022908:0
900 shares0Common StockSEC:0001415889-24-019551:0
2,000 shares@ US$76.362.7% of flowCommon StockSEC:0001415889-24-017414:0
1,310 shares@ US$76.261.7% of flowCommon StockSEC:0001415889-24-013238:0
1,680 shares@ US$224.006.6% of flowCommon StockSEC:0001415889-24-005245:0
2,000 shares@ US$88.033.1% of flowCommon StockSEC:0001415889-23-014891:0
2,000 shares@ US$88.033.1% of flowCommon StockSEC:0001415889-23-012408:0
2,000 shares@ US$88.033.0% of flowCommon StockSEC:0001415889-23-007817:0
3 shares@ US$130.240.0% of flowCommon StockSEC:0001104659-23-055524:0
Canonical exit: 15 Oct 2017 (T+90)
2,000 shares@ US$88.033.1% of flowCommon StockSEC:0001415889-23-005017:0
2,000 shares@ US$88.033.1% of flowCommon StockSEC:0001415889-23-000308:0
1,500 shares@ US$88.032.4% of flowCommon StockSEC:0001415889-22-011591:0
1,500 shares@ US$63.901.8% of flowCommon StockSEC:0001415889-22-008821:0
2,000 shares@ US$63.900.0005% mcap6.4% of flowCommon StockSEC:0001415889-22-005241:0
2,000 shares@ US$63.900.0005% mcap6.2% of flowCommon StockSEC:0001415889-22-003960:0
2,000 shares@ US$88.030.0007% mcap8.5% of flowCommon StockSEC:0001415889-22-003051:0
25 of 32 declarations
